Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188432 | SCV000242045 | uncertain significance | not provided | 2013-05-03 | criteria provided, single submitter | clinical testing | p.Gly223Val (GGG>GTG): c.668 G>T in exon 7 of the PNKP gene (NM_007254.2) The Gly223Val missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The amino acid substitution is conservative as both Glycine and Valine are uncharged, non-polar amino acid residues. Gly223Val alters a position that is not highly conserved in the DNA phosphatase domain of the PNKP protein. However, other missense mutations have not been reported at nearby codons. In addition, while one in-silico algorithm predicts Gly223Val is damaging to the structure/function of the protein, other algorithms predict it is not pathogenic. Therefore, based on the currently available information, it is unclear whether Gly223Val is is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). |